← Eichor
Condition: Tdp 43 Proteinopathies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tdp 43 Proteinopathies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
NA · 1 location(s) · Chulalongkorn University · NCT07067229Clinical Research in ALS Study
Phase N/A · 1 location(s) · University of Miami · NCT00136500The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients Wi
NA · 1 location(s) · Seoul National University Hospital · NCT06363357Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
Phase 4 · 1 location(s) · Peking University Third Hospital · NCT05923905Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration
NA · 1 location(s) · Università degli Studi di Brescia · NCT07316413GENetic Fronto Temporal Dementia Initiative in Lille
NA · 1 location(s) · University Hospital, Lille · NCT04639622A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-
Phase N/A · 1 location(s) · Biogen · NCT07259980Clinical Outcome Assessment for AT & BCI
NA · 1 location(s) · Shirley Ryan AbilityLab · NCT07407725Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
Phase N/A · 1 location(s) · Loma Linda University · NCT04097158Study of COYA 302 for the Treatment of ALS
Phase 2 · 25 location(s) · Coya Therapeutics · NCT07161999Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Phase N/A · 1 location(s) · Western University · NCT05779813Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Phase 2 · 3 location(s) · Johns Hopkins University · NCT05386394The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
Phase N/A · 1 location(s) · University of Miami · NCT00317616AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Phase 1 · 5 location(s) · Institute for Molecular Medicine · NCT07158905Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Phase 3 · 47 location(s) · Prilenia · NCT07322003Functional Outcomes and Control Using Synchron BCI - Australia
NA · 1 location(s) · Synchron, Inc. · NCT07533903Intestinal Microbiome Transplant in ALS
Phase 1/Phase 2 · 1 location(s) · Duke University · NCT07017946Speech and Language Interventions for Italian People With PPA
Phase N/A · 2 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT06739967Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT06608004First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
Phase 1/Phase 2 · 1 location(s) · David Wilson · NCT05374278Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)
NA · 1 location(s) · National Taiwan University Hospital · NCT07726563HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial
Phase 2/Phase 3 · 4 location(s) · Universidade Federal do Rio Grande do Norte · NCT06719947Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT04882904Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT03225144A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Fro
Phase 1/Phase 2 · 19 location(s) · AviadoBio Ltd · NCT06064890FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Poten
NA · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT07110207Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
NA · 1 location(s) · Johns Hopkins University · NCT07521930Proteinopathies Expression in Skin of Neurodegenerative Disorders
Phase N/A · 1 location(s) · Universidad Autonoma de San Luis Potosí · NCT06528964Control Cohort CTRL COH
NA · 1 location(s) · Hospices Civils de Lyon · NCT05370079
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.